Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Neurology
•
Vascular Neurology
•
Hospital Medicine
•
Primary Care
•
General Primary Care
•
General Hospital Medicine
Do you prescribe GLP-1 agonists to diabetic patients admitted with minor CVA or TIA for secondary stroke prevention, as suggested by the LAMP trial?
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2840370
Related Questions
What is your approach to a situation where DILI is suspected secondary to an important medication (e.g., anticoagulation, antibiotics, etc.), but the diagnosis is uncertain and the liver injury is relatively mild?
Would you empirically cover anaerobic organisms when treating non-purulent facial cellulitis if oral source (e.g., mucocutaneous lesion) was suspected?
What do you think about using conventional thoracic imaging methods (e.g., X-ray, CT, etc.) to determine if a pleural effusion is of adequate size to consider thoracentesis?
How do you consider and approach transition to hospice in a patient with HFrEF who does not appear to tolerate GDMT?
What is your approach to iron supplementation in patients with an active infection?
Do you have any concerns about lower extremity compression (e.g., compression stockings, intermittent pneumatic compression, etc.) worsening ascites in a patient with portal hypertension?
How do you consider sending fungal studies in a patient with pneumonia?
How do you decide when to initiate antibiotics for superimposed bacterial pneumonia in patients with influenza?
How do you consider the clinical relevance of elevated serum B12 levels as a marker of underlying hepatic disease?
How do you decide when to use acid-suppressive medications for GI prophylaxis when patients are on prolonged corticosteroid therapy?
